Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
      QxMD      Google Scholar   
Citation:
Blood vol 118 (15) 4053-4061
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
522   523   566   635  
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA035267, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, CA-35090, CA-35195, U10 CA037404, U24 CA114740, N01 CA035119, CA-114740, U10 CA035195, CA-35103, CA-25224, CA-35113, U10 CA035101, U10 CA035113, U10 CA063849, P50 CA097274, U10 CA035431, U10 CA035119, CA-37417, CA-35269, CA-35101, U10 CA025224, P50 CA97274, U10 CA035090, CA-35267, CA-63849, U10 CA035103  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
NCCTG-N0489
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Clinical Trials and Observations, Lymphoid Neoplasia